Obesity Promotes Aerobic Glycolysis in Prostate Cancer Cells

REFERENCES

• Park YS and Kim JS: Obesity phenotype and coronary heart disease risk as estimated by the framingham risk score. J Korean Med Sci 27, 243–249, 2012.
   PubMed Web of Science ®Google Scholar
• Vrazic H, Sikic J, Lucijanic T, Starcevic B, Samardzic P, Trsinski D, et al.: The prevalence of overweight and obesity among Croatian hospitalized coronary heart disease patients. Coll Antropol 36(Suppl 1), 211–216, 2012.
   PubMedGoogle Scholar
• Efstathiou JA, Chen MH, Renshaw AA, Loffredo MJ, and D’Amico AV: Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Cancer 109, 1493–1498, 2007.
   PubMed Web of Science ®Google Scholar
• Stryjewski PJ, Janus B, Krupa E, Nessler B, Badacz L, et al.: [Prevalence of age, gender and body weight on the frequency of hypertension and diabetes mellitus in patients hospitalized in cardiology department]. Przegl Lek 68, 585–587, 2011.
   PubMedGoogle Scholar
• Kishida K, Funahashi T, and Shimomura I: Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective. Curr Diabetes Rev 8, 84–91, 2012.
   PubMedGoogle Scholar
• Fowke JH, Motley SS, Concepcion RS, Penson DF, and Barocas DA: Obesity, body composition, and prostate cancer. BMC Cancer 12, 23, 2012.
   PubMed Web of Science ®Google Scholar
• Bassett JK, Severi G, Baglietto L, Macinnis RJ, Hoang HN, et al.: Weight change and prostate cancer incidence and mortality. Int J Cancer 131, 1711–1719, 2012.
   PubMed Web of Science ®Google Scholar
• Jayachandran J, Banez LL, Aronson WJ, Terris MK, Presti JC, Jr., et al.: Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer 115, 5263–5271, 2009.
   PubMed Web of Science ®Google Scholar
• Cao Y and Ma J: Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 4, 486–501, 2011.
   PubMed Web of Science ®Google Scholar
• Nunez NP, Hursting SD, Yakar S, Fowler D, and Vinson C: Obesity provides a permissive milieu in inflammation-associated carcinogenesis: analysis of insulin and IGF pathways. Methods Mol Biol 512, 29–37, 2009.
   PubMedGoogle Scholar
• Price RS, Cavazos DA, De Angel RE, Hursting SD, and Degraffenried LA: Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells. Prostate Cancer Prostatic Dis 15, 135–143, 2012.
   PubMed Web of Science ®Google Scholar
• Fenton JI, Nunez NP, Yakar S, Perkins SN, Hord NG, et al.: Diet-induced adiposity alters the serum profile of inflammation in C57BL/6N mice as measured by antibody array. Diabetes Obes Metab 11, 343–354, 2009.
   PubMed Web of Science ®Google Scholar
• Brunetti L, Leone S, Chiavaroli A, Orlando G, Recinella L, et al.: Cafeteria diet increases prostaglandin E2 levels in rat prostate, kidney and testis. Int J Immunopathol Pharmacol 23, 1073–1078, 2010.
   PubMed Web of Science ®Google Scholar
• Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, et al: Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2, ra73, 2009.
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Lunt SY, Dayton TL, Fiske BP, Israelsen WJ, et al.: Metabolic Pathway Alterations that Support Cell Proliferation. Cold Spring Harb Symp Quant Biol 76, 325–334, 2011.
   PubMedGoogle Scholar
• Niecknig H, Tug S, Reyes BD, Kirsch M, Fandrey J, et al.: Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia. Free Radic Res 46, 705–717, 2012.
   PubMed Web of Science ®Google Scholar
• Luo W and Semenza GL: Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget 2, 551–556, 2011.
   PubMed Web of Science ®Google Scholar
• Luo W, Hu H, Chang R, Zhong J, Knabel M, et al.: Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732–744, 2011.
   PubMed Web of Science ®Google Scholar
• Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144, 646–674, 2011.
   PubMed Web of Science ®Google Scholar
• Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100, 57–70, 2000.
   PubMed Web of Science ®Google Scholar
• Klink JC, Banez LL, Gerber L, Lark A, Vollmer RT, et al.: Intratumoral inflammation is associated with more aggressive prostate cancer. World J Urol 31, 1497–1503, 2013.
   PubMed Web of Science ®Google Scholar
• Han Y and Chen JZ: Oxidative stress induces mitochondrial DNA damage and cytotoxicity through independent mechanisms in human cancer cells. Biomed Res Int 2013, 825065, 2013.
   Google Scholar
• Janke K, Brockmeier U, Kuhlmann K, Eisenacher M, Nolde J, et al.: Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2). J Cell Sci 126, 2629–2640, 2013.
   PubMed Web of Science ®Google Scholar
• Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, et al: Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496, 238–242, 2013.
   PubMed Web of Science ®Google Scholar
• Zhong H, Hanrahan C, van der Poel H, and Simons JW: Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells. Biochem Biophys Res Commun 284, 352–356, 2001.
   PubMed Web of Science ®Google Scholar
• Zhong H, Semenza GL, Simons JW, and De Marzo AM: Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev 28, 88–93, 2004.
   PubMedGoogle Scholar
• Jung SN, Yang WK, Kim J, Kim HS, Kim EJ, et al.: Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 29, 713–721, 2008.
   PubMed Web of Science ®Google Scholar
• Margalit DN, Kasperzyk JL, Martin NE, Sesso HD, Gaziano JM, et al.: Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians’ Health Study. Int J Radiat Oncol Biol Phys 83, 28–32, 2012.
   PubMed Web of Science ®Google Scholar
• Hoque A, Albanes D, Lippman SM, Spitz MR, Taylor PR, et al: Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control 12, 627–633, 2001.
   PubMed Web of Science ®Google Scholar
• Hertz N and Lister RE: Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study. J Int Med Res 37, 1961–1971, 2009.
   PubMed Web of Science ®Google Scholar
• Kim JW, Tchernyshyov I, Semenza GL, and Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3, 177–185, 2006.
   PubMed Web of Science ®Google Scholar